Form 4 · Filed May 26, 2026, 11:33 PM UTC
KALV/KalVista Pharmaceuticals, Inc.
Audhya Paul K. — CHIEF MEDICAL OFFICER
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 22, 2026 | S | sell | 2,685 | $27 | $71,916 | 147,499 |
| May 21, 2026 | M | other | 6,250 | — | — | 150,184 |
| May 21, 2026 | M | other | 6,250 | — | — | 68,750 |
Source: SEC EDGAR raw filing ↗ · Accession 0001860131-26-000007